§ 2-802. Price gouging in sale of an essential off-patent or generic drug prohibited
West's Annotated Code of MarylandHealth--GeneralEffective: October 1, 2017
Effective: October 1, 2017
MD Code, Health - General, § 2-802
§ 2-802. Price gouging in sale of an essential off-patent or generic drug prohibited
(a) A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off-patent or generic drug.
(b) It is not a violation of subsection (a) of this section for a wholesale distributor to increase the price of an essential off-patent or generic drug if the price increase is directly attributable to additional costs for the drug imposed on the wholesale distributor by the manufacturer of the drug.
Credits
Added by Acts 2017, c. 818, § 1, eff. Oct. 1, 2017.
MD Code, Health - General, § 2-802, MD HEALTH GEN § 2-802
Current through legislation effective through May 9, 2024, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
| End of Document |